Synthetic cells that function as autonomous systems for producing an anti-cancer protein inside the body are developed.
Results for "cancer"
Targeted, ROS-Promoted Nanomedicine for Cancer Treatment
A novel reactive oxygen species (ROS)-promoted nanomedicine platform can effectively inhibit tumor growth, reduce side effects experienced in common anticancer drugs, while promote on-target uptake.
Immunoengineering with Biomaterials for Enhanced Cancer Immunotherapy
Biomaterials are engineered to improve the safety and efficacy of current cancer immunotherapies.
MicroRNAs and RNA Editing: Roles in Cancer Initiation and Progression
A study on the mechanisms and effects of RNA and microRNA editing on the initiation and progression of cancer.
Cold-Inducible RNA Binding Protein in Cancer and Inflammation
Cold-inducible RNA binding protein (CIRP) in human cancers is reviewed, where it has been implicated in tumor suppression and promotion.
Cover Art – Biomaterials, Cancer Nanomedicine and Macroporous Hydrogels
Latest Advanced Healthcare Materials covers.
A Potent Magnetic Fluid Hyperthermia Agent for Cancer Treatment
Researchers develop a new anticancer agent composed of magnesium shallow-doped iron oxide superparamagnetic nanoparticles (SPNPs). The magnetic fluid hyperthermia (MNFH) agent is highly biocompatible and is able to completely eradicate Hep3B-induced tumors.
Cancer Invasion Rate Modulated by Microenvironment Stiffness
An approach to study tumor cell invasiveness by exploiting an innovative class of polymeric scaffolds based on two-photon lithography to control the stiffness of deterministic microenvironments in 3D is presented.
Multimodal Agent for Cancer Diagnostics and Therapeutics
Chunmeng Shi and co-workers from the Third Military Medical University in Chongqing, China, introduce a small-molecule-based cancer theranostic agent for simultaneous cancer-cell mitochondrial targeting, NIR imaging, and chemo-/PDT/PTT/multimodal therapeutic activities.
Ancient and Modern Hints: Chemotherapy Resistance in Ovarian Cancer
RNA-binding proteins influence epithelial ovarian cancer progression through complex networks with mRNAs, non-coding RNAs and other proteins.
Popular
-
New theory suggests gravity is not a fundamental force
-
Higgs boson may be driving the Universe’s expansion
-
Water-powered gadgets may be on the horizon thanks to new evaporation-based energy device
-
Scientists discover a new class of antibiotics
-
Micron-sized hidden dimensions could solve two of physics’ deepest puzzles
-
A new type of dark matter could explain mysterious radiation from the Milky Way’s core